Sugi Predict

Sugi Predict / Compounds / SCHEMBL4170177

SCHEMBL4170177

SCHEMBL4170177

Cc1cc(Nc2cnc(C(=O)N(C)CC(N)=O)c(Nc3ccc(Cl)cc3)n2)n[nH]1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 1/20 0.40
▸ AURKA O14965 6/20 0.39
▸ PAK4 O96013 7/20 0.38
▸ PLK4 O00444 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ AURKB Q96GD4 3/20 0.37
▸ BTK Q06187 1/20 0.37
▸ CSNK2A1 P68400 1/20 0.37
▸ AURKC Q9UQB9 1/20 0.36
▸ SYK P43405 1/20 0.36
▸ NTRK1 P04629 1/20 0.36
▸ SRC P12931 1/20 0.36
▸ GSK3B P49841 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4170988 0.88 RET (0.42) RETAURKAPAK4PLK4MEN1
SCHEMBL4013534 0.88 AURKA (0.43) RETAURKAPAK4PLK4MEN1
SCHEMBL4180080 0.87 RET (0.40) RETAURKAPAK4PLK4MEN1
SCHEMBL4171606 0.86 AURKA (0.44) RETAURKAPAK4PLK4MEN1
SCHEMBL4160448 0.84 RET (0.45) RETAURKAPAK4PLK4MEN1
SCHEMBL4178714 0.83 CSNK2A1 (0.45) RETAURKAPAK4PLK4MEN1
SCHEMBL4171041 0.81 POLB (0.45) RETAURKAPAK4PLK4MEN1
SCHEMBL4173212 0.81 RET (0.44) RETAURKAPAK4PLK4MEN1
SCHEMBL4176412 0.80 RET (0.45) RETAURKAPAK4PLK4MEN1
SCHEMBL4304592 0.79 RET (0.47) RETAURKAPAK4PLK4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2009-10-29 — — US claimed
WO-2009089042-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2009-07-16 — — WO claimed
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2009-10-29 — — US disclosed
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2009-10-29 — — US disclosed
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2009-10-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH MAP3K1, MAP3K15, MAP3K5 RET 370/4885AURKA 408/4885PAK4 463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.